Skip to main content
OpenTrials
Completed

NCT Number: NCT01626716

Collaborative Care for Depressed Elderly in Korea

Late-life depression is associated with physical limitations, greater functional impairment, increased utilization and cost of health care, and suicide. Collaborative care, linking primary and mental health specialty care, has been shown to be effective for the treatment of late-life depression in primary care settings in Western countries. The primary aim of this project is to implement a depression care management intervention, and examine its effectiveness on the depressive symptoms of older patients in Korean primary care settings. Based on chronic disease management theory and previous Collaborative care management studies in western countries, we propose to test a Depression Care Management intervention,which includes care manager to support a primary care physician of depression in their old patients. Care manager'd role are monitoring the progress of treatment, supporting patient's adherence, educating patients/ family and facilitate communication between providers. Also psychiatrists provide consultation and supervision of care managers. Using a randomized controlled design, we will examine whether the Depression care management is an effective treatment for patients with late life depression in rural Korea. The primary outcome would be the improvement of depressive symptoms of patients in primary care setting.

Completed

Looking for future studies?

Notify Me

Key information

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chungju community health care center

Chungju, ChoongBuk, 123456, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 60 year or older
  • diagnosed depression based on DSM-IV criteria

Exclusion criteria

  • impairment of hearing
  • dementia
  • other psychiatric disorders

Treatment and study plan

Care Management

Other

patients who assigned to the intervention group will take 7 times phone calls from case manager

Primary outcomes

  1. Reduced depression symptoms

    Time frame: 3 months

    HAMD (Hamilton Depression Ratind Scale) Difference HAMD score between the intervention and control group from baseline to 3 month follow-up

Secondary outcomes

  1. Depression response and remissionhealth related quality of life

    Time frame: 3months and 6months

    HAMD (Hamilton Depression Ratind Scale) Depression response is defined by improvement 50% or more HAMD scores from baseline to each follow-up periods.

    Depression remission is defined by 7 or less of HAMD score at each follow-up periods

  2. Reduced suicide ideation

    Time frame: 3 months and 6 months

    SSI (Beck's suicide ieation scale) Difference total SSI scores Between the two groups from baseline to each follow-up periods

  3. Improvement of Quality of life

    Time frame: 3 months and 6 months

    EQ5D Difference EQ5D scores Between the two groups from baseline to each follow-up periods

Sponsors and collaborators

Lead sponsor

National Clinical Research Coordination Center, Seoul, Korea

Other Gov

Registry information

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Jun 25, 2012
Registry last updated
Mar 11, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.